In reference to other components of the metabolic syndrome, Crocetto et al. describe the ratio of triglycerides to High-Density Lipoprotein (HDL) and the extent of Pseudocholinesterase (PChE) activity as potential markers for Bladder cancer existence and their potential roles as screening for the disease [40]. The gene discussed is BCHE; the disease is urinary bladder cancer.